Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Robotic Surgery Complications Extensively Underreported

By HospiMedica International staff writers
Posted on 12 Sep 2013
A new study suggests that device-related robotic surgery complications reported to the US Food and Drug Administration (FDA) are grossly underreported.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) searched the FDA device-related complications database, LexisNexis, news media reports, and the public access to court electronic records (PACER) to identify robotic surgery-related complications over a 12-year period (January 1, 2000 to August 1, 2012). More...
Cases from LexisNexis and PACER were cross-referenced with the FDA database to determine cases where FDA reports were inaccurate, filed late, or not filed.

The results showed that although more than one million robotic surgeries have been performed in the US since 2000, hospitals only reported 245 complications to the FDA during the study period, including 71 deaths and 174 nonfatal injuries; median time to report an event was 30 days. Eight cases were identified from the LexisNexis and PACER searches where FDA reports were improperly filed. In five of these, no report was filed within a mean follow-up of 4.1 years. In the three cases where a report was filed, the mean time between the event and the FDA report was almost two years.

While complications such as excessive bleeding were reported, there were other problems that may not have been reported correctly, or at all, the researchers speculated. For example, surgeons can accidentally cut the aorta during robotic surgery because they cannot feel how firm it is, but the data was unclear as to whether this would be reported as a surgeon- or device-related problem. They also cited a previous study in which nearly 57% of surgeons surveyed anonymously said that they had to convert to laparoscopic or open surgery after the robotic device malfunctioned; it is unclear how, or if, those errors are reported with the FDA. The study was published in the August 27, 2013, issue of the Journal for Healthcare Quality.

“The number reported is very low for any complex technology used over a million times. Decisions should not be made based on the information in the FDA database,” said study author associate professor of surgery Martin Makary, MD, of the JHU School of Medicine. “A broader roster of errors must be tracked as device-related problems. We need to be able to give patients answers to their questions about safety and how much risk is associated with the robot.”

Related Links:
Johns Hopkins University




Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.